Melanie Alpaugh

Guelph, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Dietary nitrate and resveratrol co-supplementation prevent HFD-mediated impairments in carotid blood flow and behavioral parameters in male mice.

Dietary nitrate and resveratrol co-supplementation prevent HFD-mediated impairments in carotid blood flow and behavioral parameters in male mice.

Journal: Physiological reports

Published: November 24, 2025

The impact of tau deletion on Huntington's disease: An in vivo perspective.

The impact of tau deletion on Huntington's disease: An in vivo perspective.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 21, 2025

Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.

Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.

Journal: Journal of neurology

Published: December 23, 2024

Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson's disease-like neurodegeneration.

Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson's disease-like neurodegeneration.

Journal: Fluids and barriers of the CNS

Published: December 15, 2024

Investigating the Interplay between Cardiovascular and Neurodegenerative Disease.

Investigating the Interplay between Cardiovascular and Neurodegenerative Disease.

Journal: Biology

Published: August 20, 2024

Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.

Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.

Journal: Neurobiology of disease

Published: June 19, 2024

Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24].

Corrigendum to "Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: In vivo evidence using a parabiosis model" [Neurobiol Dis. 2023 May;180:106091. doi:10.1016/j.nbd.2023.106091. Epub 2023 Mar 24].

Journal: Neurobiology of disease

Published: September 18, 2023

Plasma GFAP and its association with disease severity in Huntington's disease.

Plasma GFAP and its association with disease severity in Huntington's disease.

Journal: Journal of neurology

Published: August 19, 2023

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model.

Understanding the role of the hematopoietic niche in Huntington's disease's phenotypic expression: in vivo evidence using a parabiosis model.

Journal: Neurobiology of disease

Published: January 19, 2023

Detection of antibodies against the huntingtin protein in human plasma.

Detection of antibodies against the huntingtin protein in human plasma.

Journal: Cellular and molecular life sciences : CMLS

Published: May 20, 2022

Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance.

Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance.

Journal: Molecular psychiatry

Published: October 29, 2021

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson's disease.

Journal: Nature communications

Published: October 23, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026